Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sunecos is a clinical-stage biotechnology company focused on developing innovative solutions for sun protection and the prevention of skin damage caused by ultraviolet (UV) radiation. A spin-off from the University of Siena, the company utilizes its proprietary SunEcos technology to create advanced topical formulations that mimic natural skin protection mechanisms. Their lead programs aim to provide superior photoprotection compared to traditional sunscreens, specifically targeting the prevention of skin cancer and managing photosensitivity disorders. Sunecos is positioned at the intersection of dermatology and biotechnology, leveraging academic research to address unmet needs in skin health and UV-related pathologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sunecos.